The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter
Abstract
For effective gene therapy of chronic disease, persistent transgene expression at therapeutic levels is required. Clinical studies of airway gene transfer in patients with cystic fibrosis (CF) have resulted in short-lived transgene expression. We used intra-nasal dosing of naked plasmid DNA to the murine lung as a model for investigating the duration of airway gene transfer from a series of reporter expression plasmids. Transgene expression was transient when mediated by the viral promoters CMV, RSV and SV40, falling to less than 10% of peak expression after 2 weeks, although the presence of the adenoviral E4ORF3 gene in cis, resulted in extended duration of reporter activity from the CMV promoter. Transient expression from these promoters was not due to loss of the vector as determined by quantitative TaqMan PCR analysis. However, use of the promoters from the human polybiquitin C (UbC) and the elongation factor 1alpha (EF1alpha) genes resulted in persistent gene expression in the mouse lung. The UbC promoter directed high-level reporter activity which was maintained for up to 8 weeks and was still detectable 6 months after a single administration. Such persistent airway transgene expression from a nonviral vector without the concomitant expression of a potential antigen has not been reported previously. Thus, despite the persistence of vector DNA in vivo, attenuation of promoter function may lead to silencing of transgene expression and careful selection of promoter sequenc…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“thus providing the relevant advantage of minimizing the potential risk of on-target chromosomal translocations61.”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [61]
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
Lee, E. R., Marshall, J., Siegel, C., Jiang, C., Yew, N. S., Nichols, M., Nietupski, J. B., Ziegler, R. J., Lane, M. B., Wang, K. X., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1701 · Cited by 443
DNA Methylation and Silencing of Gene Expression
Newell-Price, J. D. C., Clark, A. J. L., & King, P. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00248-4 · Cited by 330
Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., & Bromberg, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2019 · Cited by 315
Role of covalent modifications of histones in regulating gene expression
Spencer, V. A., & Davie, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00405-9 · Cited by 306
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 277
Uetsuki, T., Naito, A., Nagata, S., & Kaziro, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83619-5 · Cited by 272
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.
Carvalho, T., Seeler, J.-S., Öhman, K., Jordan, P., Pettersson, U., Akusjärvi, G., Carmo‐Fonseca, M., & Dejean, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.45 · Cited by 267
Gill, D. R., Southern, K. W., Mofford, K., Seddon, T., Huang, L., Sorgi, F., Thomson, A. H., MacVinish, L. J., Ratcliff, R. A., Bilton, D., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300391 · Cited by 262
Self-citationRepeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
Hyde, S. C., Southern, K., Gileadi, U., Fitzjohn, E., Mofford, K., Waddell, B., Gooi, H. C., Goddard, C., Hannavy, K., Smyth, S., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301212 · Cited by 230
Self-citationYew, N. S., Zhao, H., Wu, I., Song, A., Tousignant, J. D., Przybylska, M., & Cheng, S. H. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0036 · Cited by 221
The Human Ubiquitin C Promoter Directs High Ubiquitous Expression of Transgenes in Mice
Schorpp, M., Jäger, R., Schellander, K., Schenkel, J., Wagner, E. F., Weiher, H., & Angel, P. E. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1787 · Cited by 203
Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse Liver
Chen, Z.-Y., Yant, S. R., He, C.-Y., Meuse, L. A., Shen, S., & Kay, M. A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0278 · Cited by 186
Gene silencing as a threat to the success of gene therapy
Bestor, T. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9459 · Cited by 182
Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
Armentano, D., Zabner, J., Sacks, C. R., Sookdeo, C., Smith, M. P., George, J. A. S., Wadsworth, S. C., Smith, A. E., & Gregory, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2408-2416.1997 · Cited by 182
Freimark, B. D., Blezinger, H. P., Florack, V. J., Nordstrom, J. L., Long, S. D., Deshpande, D., Nochumson, S., & Petrak, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4580 · Cited by 178
Baskar, J. F., Smith, P. P., Nilaver, G., Jupp, R. A., Hoffmann, S. R. K., Peffer, N. J., Tenney, D. J., Colberg‐Poley, A. M., Ghazal, P., & Nelson, J. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3207-3214.1996 · Cited by 165
Gene silencing and DNA methylation processes
Paszkowski, J. (2001) · Current Opinion in Plant Biology · doi:10.1016/s1369-5266(00)00147-3 · Cited by 146
Hérissé, J., Rigolet, M., de Dinechin, S. D., & Galibert, F. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.16.4023 · Cited by 120
Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells
Yew, N. S., Wysokenski, D. M., Wang, K. X., Ziegler, R. J., Marshall, J., McNeilly, D., Cherry, M., Osburn, W., & Cheng, S. H. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.5-575 · Cited by 113
A Consensus Sequence for the Adenovirus-2 Genome
Roberts, R. J., Akusjärvi, G., Aleström, P., Gelinas, R. E., Gingeras, T., Sciaky, D., & Pettersson, U. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2293-1_1 · Cited by 91
Brough, D. E., Hsu, C., Kulesa, V., Lee, G. M., Cantolupo, L. J., Lizonová, A., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9206-9213.1997 · Cited by 91
Lægreid, A., Medvedev, A. E., Nonstad, U., Bombara, M. P., Ranges, G. E., Sundan, A., & Espevik, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37355-6 · Cited by 84
Sung, R. S., Qin, L., & Bromberg, J. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0318 · Cited by 83
Towards gene therapy for cystic fibrosis: a clinical progress report
Alton, E. W. F. W., Geddes, D. M., Gill, D. R., Higgins, C. F., Hyde, S. C., Innes, J., & Porteous, D. J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300655 · Cited by 60
Self-citationAdenovirus DNA : the viral genome and its expression
Doerfler, W. (1986) · Cited by 52
Kuriyama, S., Sakamoto, T., Kikukawa, M., Nakatani, T., Toyokawa, Y., Tsujinoue, H., Ikenaka, K., Fukui, H., & Tsujii, T. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300738 · Cited by 48
Promoter attenuation in gene therapy: causes and remedies.
Paillard, F. (1997) · PubMed · Cited by 43
Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3 cells
Nenoi, M., Mita, K., Ichimura, S., Cartwright, I. L., Takahashi, E.-I., Yamauchi, M., & Tsuji, H. (1996) · Gene · doi:10.1016/0378-1119(96)00145-x · Cited by 32
Immune effects and therapeutic applications of CpG motifs in bacterial DNA
Krieg, A. Μ., & Kline, J. N. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00228-9 · Cited by 29
Yew, N. S., Marshall, J., Przybylska, M., Wysokenski, D. M., Ziegler, R. J., Rafter, P. W., Li, C. Q., Armentano, D., & Cheng, S. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950017518 · Cited by 23
Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epithelium
Hillery, E., Cheng, S. H., Geddes, D. M., & Alton, E. W. F. W. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300953 · Cited by 12
Cited by
Sorted by citations
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Chen, Z.-Y., He, C.-Y., Ehrhardt, A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00168-0 · Cited by 463
Baldi, L., Hacker, D. L., Adam, M., & Wurm, F. M. (2007) · Biotechnology Letters · doi:10.1007/s10529-006-9297-y · Cited by 328
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., Nunez-Alonso, G. A., Green, A.-M., Bazzani, R. P., Jones, S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1399 · Cited by 308
Self-citationKonstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298
Metadata
- Authors
- Gill, D., Smyth, S., Goddard, C., Pringle, I., Higgins, C., Colledge, W., & Hyde, S.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Cambridge (GB)
- Hammersmith Hospital (GB)
- Venue
- Gene Therapy
- Published
- 2001-10-01
- Volume
- 8
- Issue
- 20
- Pages
- 1539-1546
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2122003649
- Cited by
- 214
- References
- 34
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 12
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Cystic Fibrosis Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- persistent transgene expression, pulmonary gene therapy, promoter selection, cystic fibrosis, promoter silencing, reporter gene expression
- MeSH terms
- Administration, Inhalation, Animals, Avian Sarcoma Viruses, Cell Line, Cystic Fibrosis, Cytomegalovirus, Female, Gene Expression Regulation, Genetic Vectors, Humans, Luciferases, Lung, Mice, Inbred BALB C, Plasmids, Promoter Regions, Genetic, Simian virus 40, Time Factors, Genetic Therapy, Statistics, Nonparametric, Transgenes, Peptide Elongation Factor 1, Models, Animal, Ubiquitin C, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review